Biotech

All Articles

Arch closes $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund from Bain Resources Lifestyle Sciences, Arch Endeavor Partners is...

Orion to utilize Aitia's 'electronic twins' to discover new cancer drugs

.Finnish biotech Orion has snooped possible in Aitia's "electronic double" technician to develop bra...

Windtree's shock med rears high blood pressure in latest phase 2 gain

.While Windtree Rehabs has had a hard time to grow the financial origins required to make it through...

2 cancer biotechs combine, creating international footprint

.OncoC4 is taking AcroImmune-- as well as its own in-house medical production abilities-- under its ...

Amgen records very first phase 3 gain for $400M eczema medication

.Amgen has actually discussed (PDF) the initial phase 3 information on its own $400 million dermatit...

Biogen, UCB report period 3 lupus gain after falling short earlier test

.Biogen as well as UCB's gamble on advancing into phase 3 on the back of an unsuccessful research st...

Aptadir really hopes new RNA preventions may turn around difficult cancers cells

.Italian biotech Aptadir Therapies has actually launched along with the pledge that its pipeline of ...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Surge Lifestyle Sciences has satisfied its objective in a Duchenne muscular dystrophy (DMD) researc...

Sanofi plucks new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, occupying the...

Achilles droplets cell therapy course, bandages for layoffs after overlooking 'business viability' targets

.Achilles Therapeutics has actually torn up its own method. The British biotech is quiting working o...